Inventor · San Francisco, CA, US

Bradley Backes

16Patents
2h-index
31Co-inventors
54Inventor score

Filing activity: May 25, 2001 → Nov 12, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6680178B2 Profiling of protease specificity using combinatorial fluorogenic substrate libraries Chemistry; Metallurgy 99 Expired
US7329393B2 Capacity altering device, holder, and methods of sample processing Performing Operations; Transporting 7 Expired
US10822340B2 Substituted imidazolopyrazine compounds and methods of using same Human Necessities 2 Active
US10131668B2 Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1 Human Necessities 2 Active
US9988368B1 Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use Chemistry; Metallurgy 1 Active
US11111259B2 Acylsulfonamide derivatives for treating senescence-associated diseases and disorders Chemistry; Metallurgy 0 Active
US11649237B2 Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition Chemistry; Metallurgy 0 Active
US11667606B2 Thyromimetics Chemistry; Metallurgy 0 Active
US11827596B2 Thyromimetics Chemistry; Metallurgy 0 Active
US10329279B2 Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use Chemistry; Metallurgy 0 Active
US11840523B2 IRE1α inhibitors and uses thereof Chemistry; Metallurgy 0 Active
US11884649B2 IRE1α inhibitors and uses thereof Chemistry; Metallurgy 0 Active
US7629437B2 Fluorogenic materials and uses thereof Chemistry; Metallurgy 0 Expired
US7834012B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) Chemistry; Metallurgy 0 Active
US11613544B2 Substituted imidazo[1,5-a]pyrazines for modulation of IRE1 Human Necessities 0 Active
US12391669B2 Substituted pyrimidines as IRE1 kinase inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.